Investing.com -- 4basebio PLC (AIM:4BB) stock surged 6.9% on Monday after announcing that a global Tier 1 pharmaceutical partner has begun dosing patients in Phase I/II clinical trials using the ...

Monday that a global tier-one pharmaceutical partner had started dosing patients in a phase one and two US clinical trial ...

The partner firm has used 4basebio's template to develop an mRNA product which has been tested on patients in phase-one and two clinical trials, following investigational new drug approval from the US ...

Frogs have made significant contributions to Fred Hutch science over the years as a model organism that shares much of our ...

Discover how the Amazon’s purple powerhouse, the açaí berry, is being redefined by science for its role in combating ...

Scientists found a virus-like living entity in human bodies named "obelisks" - small loops of RNA, each a thousand genetic ...

Proteins are synthesized through two processes involving DNA: transcription, which converts DNA into mRNA; and translation, ...

DNA, often called the blueprint of life, is built from four chemical building blocks known as deoxy-nucleoside triphosphates ...

Maternal peanut and peanut butter consumption during pregnancy and breastfeeding shaped DNA methylation patterns in children, ...

Scientists at the University of Glasgow have harnessed a powerful supercomputer, normally used by astronomers and physicists ...